A study to investigate whether the experimental medication IMU-838 is safe and effective when it is given to Covid-19 patients in addition to their normal treatment : A Prospective, Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator’s Choice of Standard of Care Therapy, in Patients with Coronavirus Disease 19 - CALVID-1

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 13. Sept. To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [kostenfrei]

Keywords:

610
Medical Condition: COVID-19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Phase: Phase 2
Recruitment Status: Not yet recruiting
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 27-04-2020, Last updated: 2021-09-22

PPN (Catalogue-ID):

WHO004496299